Deletion of Galgt2 (B4Galnt2) Reduces Muscle Growth in Response to Acute Injury and Increases Muscle Inflammation and Pathology in Dystrophin-Deficient Mice-Reference-Cited by-同舟云学术

Deletion of Galgt2 (B4Galnt2) Reduces Muscle Growth in Response to Acute Injury and Increases Muscle Inflammation and Pathology in Dystrophin-Deficient Mice

Published:2015-10 Issue:10 Volume:185 Page:2668-2684
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Xu Rui,Singhal Neha,Serinagaoglu Yelda,Chandrasekharan Kumaran,Joshi Mandar,Bauer John A.,Janssen Paulus M.L.,Martin Paul T.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference99 articles.

1. Eteplirsen for the treatment of Duchenne muscular dystrophy;Mendell;Ann Neurol,2013

2. Dystrophin: the protein product of the Duchenne muscular dystrophy locus;Hoffman;Cell,1987

3. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals;Koenig;Cell,1987

4. Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse;Mann;Proc Natl Acad Sci U S A,2001

5. Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice;Head;Proc Biol Sci,1992

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08

2. An Identification of Functional Genetic Variants in B4GALNT2 Gene and Their Association with Growth Traits in Goats;Genes;2024-03-03

3. Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome;Clinical Cancer Research;2023-09-27

4. Molecular Genetic Therapies in the Muscular Dystrophies;Current Clinical Neurology;2023

5. A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2;Molecular Therapy - Methods & Clinical Development;2022-12